The Wall Street Journal Highlights the CF Foundation’s Drug Development Efforts

February 10, 2009

The Wall Street Journal today features an article, “Disease Charities Pursue Cures by Investing in Drug Start-Ups.” It credits the Foundation for motivating other non-profits to fund promising early-stage drug research with drug companies.

According to the article, charities are “…inspired by the success of the Cystic Fibrosis Foundation in spurring numerous companies to work on potential treatments for the rare genetic disease that kills most patients before the age of 40.”

The article mentions the Foundation’s collaboration with Vertex Pharmaceuticals Inc., involving two promising therapies known as VX-770 and VX-809.  

Read the full article.